In a significant shift for the UK’s life sciences sector, Syncona, the Wellcome Trust-backed FTSE 250 investment company, has revealed plans to implement an orderly wind-down of its portfolio assets.
Biotech2- Page
31Articles
Australian biotechnology company BPH Global has unveiled groundbreaking research revealing significant concentrations of gold and copper in seaweed, opening new possibilities for sustainable metal extraction from seawater. Recent assays conducted
Synairgen, the respiratory-focused biotechnology company born out of the University of Southampton, is set to delist from the Alternative Investment Market (AIM) following a turbulent period of funding challenges. Shareholders
British pharmaceutical giant GSK has struck a significant deal worth up to $1.15 billion to acquire IDRx, a Massachusetts-based biopharmaceutical company, strengthening its position in the oncology sector. The FTSE
Shares in Oxford Nanopore Technologies jumped 8.9 per cent today after the British gene sequencing innovator reported robust revenue growth and reaffirmed its path to profitability. The FTSE 250 company
In a significant move that marks the largest biotech acquisition since 2023, Johnson & Johnson has announced its agreement to purchase neuroscience drugmaker Intra-Cellular Therapies for £14.6 billion. The New
In a devastating blow to investor confidence, Moderna’s shares experienced a dramatic decline of up to 22 per cent on Monday following disappointing sales forecasts from the US biotech giant.
Liverpool’s burgeoning life sciences sector is positioning itself as one of Europe’s premier biotech clusters, with projections indicating up to £800 million in investment over the next decade. The region’s
A groundbreaking series A funding round has positioned London-based Verdiva Bio at the forefront of the obesity treatment sector, securing an impressive $411 million investment. This remarkable achievement stands as
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with
A groundbreaking personalised cancer treatment is emerging from an unexpected location: Stevenage High Street. UK biotech firm Autolus has received FDA approval to manufacture and distribute its innovative Car-T cell
The pharmaceutical industry has witnessed a dramatic decline in deal activity, reaching its lowest point in nearly a decade as major drugmakers pivot away from commercially ready medicines towards early-stage
The pharmaceutical industry stands on the cusp of a major transformation as revolutionary weight-loss injections demonstrate potential far beyond their initial scope. Semaglutide, marketed under brands like Ozempic and Wegovy,
In a significant development in the fight against lung cancer, doctors have initiated the world’s first mRNA lung cancer vaccine trials in patients across seven countries. This pioneering jab, known
In a groundbreaking development, brain implants are emerging as a potential game-changer in the treatment of various neurological and chronic conditions. Startups across the globe are engaging in clinical trials
- 1
- 2
